Affiliation:
1. From the Max-Planck-Institute for Physiological and Clinical Research, Bad Nauheim, Germany; the Center for Molecular Medicine, University of Köln, Köln, Germany; and the Howard Hughes Medical Institute, Harvard Medical School, Boston, MA.
Abstract
AbstractThe receptor tyrosine kinase Flk-1 is essential for embryonic blood vessel development and for tumor angiogenesis. To identify upstream transcriptional regulators of Flk-1, the gene regulatory elements that mediate endothelium-specific expression in mouse embryos were characterized. By mutational analysis, binding sites for SCL/Tal-1, GATA, and Ets transcription factors located in theFlk-1 enhancer were identified as critical elements for the endothelium-specific Flk-1 gene expression in transgenic mice. c-Ets1, a transcription factor that is coexpressed withFlk-1 during embryonic development and tumor angiogenesis, activated the Flk-1 promoter via 2 binding sites. One of these sites was required for Flk-1 promoter function in the embryonic vasculature. These results provide the first evidence that SCL/Tal-1, GATA, and Ets transcription factors act upstream ofFlk-1 in a combinatorial fashion to determine embryonic blood vessel formation and are key regulators not only of the hematopoietic program, but also of vascular development.
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Reference57 articles.
1. Vasculogenesis.;Risau;Annu Rev Cell Dev Biol.,1995
2. Mechanisms of angiogenesis.;Risau;Nature.,1997
3. Failure of blood-island formation and vasculogenesis in flk-1-deficient mice.;Shalaby;Nature.,1995
4. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant.;Millauer;Nature.,1994
5. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo.;Millauer;Cancer Res.,1996
Cited by
115 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献